Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Valeant To Acquire Synergetics USA | Contract Pharma

What are you searching for?

Sign in
Breaking News

Valeant To Acquire Synergetics USA

Further expands Bausch + Lomb portfolio

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Valeant Pharmaceuticals’ affiliate has entered into a definitive agreement to acquire Synergetics USA, Inc. in a transaction valued at $166 million, with additional sales milestones following the closing. The transaction, subject to customary closing conditions, is expected to close in 4Q15. Synergetics is a supplier of precision surgical devices with a primary focus on ophthalmology and neurosurgery.
 
“The addition of Synergetics’ portfolio of instruments and devices will further enhance Bausch + Lomb’s presence around the world in the rapidly evolving field of vitreoretinal surgery,” said J. Michael Pearson , chairman and chief executive officer of Valeant.  “We are committed to delivering a valuable and broad array of surgical devices and instruments to serve the needs of the surgical retina community and their patients.”
 
“We are pleased to reach an agreement with Valeant, which is a logical partner to maximize our Company’s growth opportunities and, importantly, this agreement creates immediate and compelling value for our shareholders,” said David M. Hable, president and chief executive officer of Synergetics.  “The combined strengths of both companies will expand the breadth of our offerings and create a more effective competitor that is better able to meet our customers’ needs in the ophthalmology and neurosurgery markets.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters